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The extra-cranial venous system is complex and not well studied in comparison to the peripheral venous system. A
newly proposed vascular condition, named chronic cerebrospinal venous insufficiency (CCSVI), described initially in
patients with multiple sclerosis (MS) has triggered intense interest in better understanding of the role of extra-
cranial venous anomalies and developmental variants. So far, there is no established diagnostic imaging modality,
non-invasive or invasive, that can serve as the “gold standard” for detection of these venous anomalies. However,
consensus guidelines and standardized imaging protocols are emerging. Most likely, a multimodal imaging
approach will ultimately be the most comprehensive means for screening, diagnostic and monitoring purposes.
Further research is needed to determine the spectrum of extra-cranial venous pathology and to compare the
imaging findings with pathological examinations. The ability to define and reliably detect noninvasively these
anomalies is an essential step toward establishing their incidence and prevalence. The role for these anomalies in
causing significant hemodynamic consequences for the intra-cranial venous drainage in MS patients and other
neurologic disorders, and in aging, remains unproven.
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The venous system is a complex, low-pressure, freely
communicating network of vessels, which contains 75%
of the body’s circulating blood volume. The main func-
tion of the venous system is to return blood to the heart
from the periphery and maintain cardiac output. Path-
ology in the peripheral venous system is frequently en-
countered and well-characterized as exemplified by
varicose veins and deep vein thrombosis [1,2].
The extra-cranial venous system is complex as com-
pared to the peripheral venous system, not well-
examined and only partially understood [3,4]. It is a* Correspondence: rzivadinov@bnac.net
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reproduction in any medium, provided the orcomplex three-dimensional (3D) structure that is often
asymmetric and represents significantly more variability
than extra-cranial arterial anatomy. For example, unlike
the carotid artery, the vascular wall of the internal jugu-
lar veins (IJVs) is much more flexible with a variable
lumen diameter which can be influenced by postural
change, respiration, cardiac function, hypovolemia and
hydration status even by the pulsation of nearby arteries
[5-10]. Even less is known about the main drainage
routes of the spine, namely the azygous venous system
and its pathophysiology. When performing imaging of
the extra-cranial venous system, it is almost impossible
to take all of the above factors into account, regardless
of the imaging modality utilized. Moreover, because of
the variant shapes and asymmetry of the IJVs, proper
sizing is complex with common under- or over-td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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stenosis [11].
Currently, literature is relatively sparse in terms of in-
vestigation of the extra-cranial venous system as com-
pared to the cerebrovascular arterial or peripheral
venous systems. For almost two decades, uni- or bi-
lateral jugular vein reflux (JVR) has been noted and re-
lated to several neurological disorders such as transient
global amnesia, transient monocular blindness, cough
headache and primary exertional headache [12-17].
However, only recently, a newly-proposed vascular con-
dition, named chronic cerebrospinal venous insufficiency
(CCSVI) [18], has generated an intense interest in better
understanding of the role of extra-cranial venous anom-
alies and developmental variants, particularly in relation
to the development of central nervous system (CNS)
pathology [10,19-26]. CCSVI has been described as a
vascular condition characterized by anomalies of the
main extra-cranial cerebrospinal venous outflow routes
that interfere with normal venous outflow in patients
with multiple sclerosis (MS) [18,27,28].
The presence of the CCSVI implies a pathological con-
dition for which diagnosis is based mainly on color Dop-
pler Sonography (DS) findings in the extra-cranial (neck)
and intra-cranial veins by assessing five venous
hemodynamic (VH) criteria (with cutoff of ≥2 positive
criteria used for diagnosis of CCSVI) [18,27]. The reli-
ability of using DS in the diagnosis of CCSVI is ques-
tionable without proper training [29-31] and has been
the focal point of recent statements from various soci-
eties [32,33].
Additional noninvasive modalities, such as magnetic
resonance venography (MRV) [30,31,34-44] or com-
puted tomography venography (CTV), may facilitate
greater intra-cranial and extra-cranial vein examination,
including that of the azygous vein in the chest, leading
to an improved knowledge in this area, specifically, the
anatomy of normal cerebrospinal venous outflow.
Although catheter venography (CV) is widely con-
sidered the “gold standard” for the assessment of vas-
cular anomalies, including CCSVI [28,34,42,43,45-51],
there is a lack of standard CV protocol or established
guidelines for optimal diagnostic assessment of CCSVI
diagnosis. There are significant differences between
CV techniques and its interpretation among angiographers
with no scientific evidence supporting a particular
angiographic technique. Moreover, the rules implied in
arterial imaging cannot be used for the imaging of
extra-cranial veins.
Venous anomalies vs. developmental variants
The venous system development through stages may be
associated with a number of developmental variants that
do not necessarily represent pathological findings [52-54].It has been reported that the extra-cranial venous anomal-
ies are likely to be truncal venous malformations [53]
characterized by intra-luminal defects, (such as flaps,
webs, septums, membranes and malformed valves)
[18,31,45] or by extra-luminal anomalies represented by
stenoses of the venous wall [18,28,31,45,46,48,49,51].
Pathological studies aimed to define the nature of these
venous anomalies/developmental variants are limited and
more investigations are needed [55,56]. Diaconu et al. ex-
amined the IJVs, the brachiocephalic veins and the azygos
vein from 20 cadavers (10 control and 10 MS patients)
and concluded that the anatomy of the extra-cranial ven-
ous system has significant variability, including a differing
number of valves in different regions and variable charac-
teristics of the valves [56]. Coen et al. examined specimens
from the IJVs of MS patients who underwent surgical re-
construction of the IJV, specimens of the great saphenous
vein used for surgical reconstruction and specimens from
patients without MS [55]. They found that extra-cranial
veins of MS patients showed focal thickenings of the
wall associated with a higher expression of type III col-
lagen in the adventitia. Further studies are needed to
define extra-cranial venous anomalies/developmental
variants that cause significant hemodynamic alterations
in the drainage of intra-cranial venous system and to
determine their incidence and prevalence in aging, MS
and other CNS disorders.
Controversy and debate that triggered need for
standardization and development of imaging procedures
Although the CCSVI hypothesis has provoked great con-
troversy and debate in the MS research community since
it was first presented [20,23,24,57-61], it gained popularity
among MS patients because of the postulated possibility
of venous insufficiency correction using endovascular pro-
cedures [28]. So far, there have been several contradictory
studies published [28,46,49,62-68] and verified scientific
evidence supportive of a causative relationship between
CCSVI and MS is lacking [10,69]. As with many promis-
ing, yet unproven therapies, many MS patients have
undergone endovascular treatment for CCSVI [70-74]. Pa-
tients have undergone these endovascular procedures in
either open-label or private care settings but largely in
non-randomized, non-blinded and poorly controlled clin-
ical settings [69]. Some of the central tensions of the
CCSVI debate are related to the fact that the safety and
efficacy of endovascular treatment have not been investi-
gated and proven to be beneficial in randomized, con-
trolled, blinded trials. So far there have been several case
reports concerning patients who had serious side effects
after angioplasty for CCSVI like IJV stent thrombosis re-
quiring open thrombectomy, stent migration, aneurysmal
vein dilatation, cranial nerves neuropathy, as well as re-
ports of lethal cases [48,49,63,75]. Because patients with
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may present with CCSVI, it is unclear whether the correc-
tion of CCSVI is necessary and whether it can lead to ob-
jectively measured improvements [76].
There is an increasing interest in imaging the extra-
cranial venous system and great need for determin-
ation of the imaging “gold standard” for the detection
of extra-cranial venous anomalies and developmental
variants [76,77]. In our view, additional research andTable 1 Advantages and disadvantages of noninvasive diagn
venous insufficiency




- without ionizing radiation
- less expensive
- high resolution
- real time information
- sensitive to detect flow changes, intra
extra-luminal abnormalities
- ability to measure velocity




- without ionizing radiation
- well established method
- operator independent
- less time consuming than DS
- provide global view of intra- and extra
venous system
- easy to blind
- ability to measure flow and velocity w
technique (phase contrast MRV)
- global view of collateral veins





- less expensive and time consuming th
- better spatial resolution than MRV
- global view of veins
- lack of experience for extra-cranial ven
Plethysmography [105,106] - noninvasive
- provides valuable information regardin
impact of reflux and obstruction on ove
venous function
- can monitor the dynamics of venous
time and evaluation of treatment outco
Legend: DS, Doppler sonography; MRV, Magnetic Resonance Venography.effort is needed until clear and uniform answers are
found [76].
This article summarizes current knowledge regarding the
advantages and disadvantages of both noninvasive and in-
vasive imaging modalities for the detection of these extra-
cranial venous anomalies and developmental variants that
have been associated with CCSVI (Tables 1 and 2). This art-
icle also describes the need for standardization and devel-
opment of guidelines.ostic methods for diagnosis of chronic cerebrospinal
Disadvantages
- no standardized guidelines
- operator dependent
- time consuming (60 to 120 minutes)
- blinding procedures are challenging
- cannot perform global view of the veins (limited
window)
- and - misidentification of the veins
- influenced by hydration status
- no real time information
- cannot detect intra-luminal abnormalities
- low specificity of conventional MRV techniques
- influenced by hydration status
- azygos vein examination needs technical improvements
due to important artifacts (breathing, heart movements)





an MRV - no real time information
- cannot detect intra-luminal abnormalities
- cannot be performed without contrast (allergy, toxicity)
ous system - less contrast resolution than MRV
- higher false-positive rate due to venous compression







Table 2 Advantages and disadvantages of invasive diagnostic methods for diagnosis of chronic cerebrospinal venous
insufficiency
Invasive diagnostic methods Advantages Disadvantages
Catheter venography
[28,34,42,43,45-51]
- considered gold standard - invasive method
- real time information can be obtained by using contrast - ionizing radiation
- ability to measure pressure - cannot be performed without contrast
(allergy, toxicity)
- provide “road map” for planning endovascular procedures - operator dependent
- can be complemented by use of more sophisticated criteria
(time to empty contrast from vein or wasting of the balloon)
- time consuming (>45 minutes)
- cannot detect intra-luminal abnormalities
- no global view of veins and collaterals




- offers a 360° view of the vessel’s wall from the inside - invasive method
- can detect intra-luminal abnormalities - lack of experience - no standardized protocols
- easily accesses all parts of IJVs in comparison with DS - ring down artifacts
- provides more accurate assessment of vein stenosis and
wall thickness than CV and DS
- geometric distortion - from imaging in an
oblique plane
- size of IVUS probe - limitation in the imaging
of severe stenosis
Legend: CV, catheter venography; DS, Doppler Sonography; IVUS, intravascular ultrasound.




DS is clinically the most useful technique for detecting, lo-
calizing and evaluating peripheral venous obstruction and
venous valvular incompetence [33,109]. The sensitivityFigure 1 Examples of chronic cerebrospinal venous insufficiency veno
anomalies noted in internal jugular vein (IJV) lumen; (B) annulus in the left IJV
expanding with respiratory or positional changes; (C) thrombus noted in IJV; (
Reflux/bidirectional flow directed towards the brain for a duration of >0.88 se
color flow, while F demonstrates reflux using spectral analysis - waveform notand specificity of venous DS for symptomatic proximal
deep vein thrombosis exceeds 90% [110,111]. Spectral ana-
lysis of the DS signal is used to confirm the presence or
absence of flow and indicates its direction and the pat-
terns. Spectral analysis of DS signal and color DS are used
to confirm the presence of reflux. It has the advantageus hemodynamic criteria on Doppler sonography. (A) Flap
: circumferential thickened vein wall that is restricting the vein from fully
D) severe stenosis of left IJV: CSA measurement of ≤3 mm2; (E and F)
conds in the right IJV in the supine position (E demonstrates reflux using
ed above baseline for more than 0.88 seconds).
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providing high-resolution images with real time dynamic
information, such as flow and velocity, showing intra-
luminal (Figure 1A) as well as extra-luminal anomalies
and developmental variants (Figure 1B) and being consid-
erably less expensive than other noninvasive imaging tech-
niques. DS imaging can also be readily applied in the
follow-up period of subjects undergoing endovascular
treatment because it can recognize the associated compli-
cations (residual stenosis, restenosis or venous throm-
bosis) (Figure 1C) [28,67,68].
Recent findings suggest that the majority of CCSVI
pathology is confined to the intra-luminal portion of
extra-cranial veins, which requires high-resolution B-
mode imaging for the visualization of these anomalies
[31,47]. The visible "stenoses" (Figure 1D) or extra-
luminal venous anomalies most likely develop more fre-
quently, merely with the progression of the disease or
age [10].
Because of the advantages of DS in detecting intra-
luminal venous pathology, it was initially promoted as a
method of choice for the screening of extra-cranial ven-
ous anomalies and developmental variants, indicative of
CCSVI [18,27]. The diagnosis of CCSVI is both based on
hemodynamic and imaging findings that utilize DS to
study the deep cerebral veins, the IJVs and the vertebral
veins (VVs) in both erect and supine positions. DS can
also assess the hemodynamic consequences of outflow
derangement while B-mode ultrasound detects struc-
tural venous intra-luminal anomalies (Figure 1E, F)
[18,27,31,33,109,112]. Zamboni et al. created a set of five
DS VH criteria by which MS patients were differentiated
from healthy controls with 100% specificity and sensitiv-
ity [18,27] (Figure 1). However, in their original publica-
tion [18], they did not recommend exact technical
procedures for the protocol application in either a re-
search or routine clinical setting. The first attempt to de-
fine the standardized CCSVI scanning protocol was
recently presented [98]. More recently, the International
Society for the Neurovascular Disease (ISNVD) devel-
oped a more comprehensive consensus document that
included the participation of more than 40 international
experts in DS imaging. DS was proposed as a standard-
ized screening tool for determining CCSVI status [33].
The protocol proposes the use of quantitative measures
for the definition of functional anomalies, such as blood
flow velocity and volume (Figure 2) that could be poten-
tially more reliable in assessing the degree of venous
outflow obstruction in the IJVs. It also refines originally
proposed VH criteria. Even more recently, the European
Society of Neurosonology and Cerebral Hemodynamics
(ESNCH) expressed considerable concerns regarding the
accuracy of the proposed criteria for CCSVI in MS [32],
and proposed the central blinded DS reading as part of arecent multi-center Italian CoSMo study investigating
the prevalence of CCSVI in MS patients, controls and
patients with OND [113].
Disadvantages
The main criticism of the recommended DS protocol is
that its reproducibility depends on the training level and
skills of the operator and it is not easy to be blinded
and standardized in either a research or clinical setting
[29-33,87]. Moreover, the value of the CCSVI VH cri-
teria is controversial because they combine functional
and structural intra- and extra-cranial venous anomal-
ies/developmental variants in a single binary composite.
Zamboni et al. used ≥2 abnormal DS VH criteria as a
cutoff for CCSVI diagnosis classification [18,27]. The di-
chotomous variable construct of the CCSVI diagnosis,
based on the arbitrary decision biased toward character-
istics of the originally studied population and on
the obtained results without further testing and valid-
ation datasets [18,27], may contribute to explaining
major inconsistencies in the prevalent findings of
CCSVI between different studies ranging from 0 to
100% [18,27,34,78-98,100,101,114]. The assessment of
the second CCSVI criterion (reflux in deep cerebral
veins) (Figure 3) is particularly controversial because the
direction of the blood flow in veins connecting cortical
with deep veins may vary considerably as a consequence
of the physiologic inter-individual variation of the cere-
bral venous anatomy [30,32,33,87].
DS also has limits regarding extra-cranial vein
characterization, since findings can be influenced by hy-
dration status [10]. DS is a very time-consuming method
and visualization of the central veins, particularly in the
thorax and abdomen, is often limited and cannot give
the global view of vein anatomy. Although it can detect
extra-cranial collateral veins, which are probably associ-
ated with CCSVI, it is not technically feasible to follow
the complete course of the collateral veins, which can
be more easily visualized with use of MRV, CTV or
CV [10]. Other pitfalls in DS imaging include the mis-
identification of veins. Additionally, overlying bone
and muscle may prevent continuous imaging (cannot
visualize suitably the confluence of the IJVs and the
subclavian vein because clavicle commonly blocks dir-
ect visualization). Similarly, the cervical part of IJV
and the jugular bulb cannot be visualized by DS be-
cause of the limited acoustic window resulting from
the spine, mandible and skull [10,112,114].
Prevalence findings of CCSVI
So far, none of the recently published DS studies [30-
32,34,78-101] have reproduced the originally reported
CCSVI prevalence [18,27], regardless of the diagnostic
DS method utilized. Even those DS studies which
Figure 2 Example of velocity (A) and volume (B) measurement over four-second phase in internal jugular vein (IJV).
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tween MS patients and the controls, reported a substan-
tially lower prevalence than was originally reported
[30,31,83,88,90,92-94,98,99].
The largest cohort published to date of MS patients
and controls with DS examined in a blinded manner
reported prevalence rates of 56.1% in MS patients, 42.3%
in those with OND, 38.1% in clinically isolated syndrome
and 22.7% in healthy controls [98]. There have been nu-
merous additional DS studies that showed significant
differences in CCSVI prevalence between MS patients
and the controls [30,31,78,83,88,90,92-95,99]. However,
an even higher number of DS studies have failed to show
prevalence differences in CCSVI between MS patients
and controls [34,80-82,84-87,89,91,96,97,100,101].Figure 3 Example of reflux in the deep cerebral veins using Quality DBy using contrast-enhanced DS to assess cerebral cir-
culation times (CCT) in MS patients and control sub-
jects, Mancini et al. showed that MS patients had a
significantly prolonged CCT and more frequent retro-
grade flow in IJVs [90].
Jugular vein reflux
Several studies have shown a relationship between IJV
drainage anomalies, characterized by JVR and specific
neurological diseases of undetermined etiology, such as
transient global amnesia [14], transient monocular blind-
ness [17], cough headache [13], primary exertional head-
ache [16], idiopathic intra-cranial hypertension [115] along
with a higher prevalence of white matter hyperintensities in
older people [15]. JVR was also investigated in a largeoppler Profile (QDP). Doppler profile on opposite sides of baseline.
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dilated vessel lumen and slowed flow velocity in the left IJV,
as well as decreased time-averaged mean velocity of bilat-
eral IJV, was found in those over 70 years of age [116].
Further considerations
The prevalence of CCSVI and JVR, as well as their rela-
tionship to clinical findings in CNS disorders, empha-
sizes the need for more quantitative and reproducible
measures for the integration of morphological and func-
tional anomalies. These include blood flow, as well as
velocity and blood volume that could be potentially
more reliable in assessing the degree of venous outflow
obstruction in the IJVs and azygous vein (Figure 2).
Contrast-enhanced exams can potentially increase the
value of DS [90]. There is a need for training and use of
standardized VH criteria for the diagnosis of CCSVI, as
recently reported [33,98]. While the value of these VH
criteria in detecting venous anomalies or developmental
variants is uncertain [32], no other validated criteria
have been proposed at this time. We hope that rapidly
growing literature will contribute to the refinement of
protocols and procedures to be utilized in the study of
the extra-cranial venous system [113].
Magnetic resonance venography
MRV is an often overlooked and underappreciated non-
invasive and safe method for the evaluation of head and
neck veins. Academic and clinical applications of MRV
are relatively meager by comparison to CV or DS [117].
In relation to DS, the advantages are driven by MRV being
a noninvasive technique, less time-consuming and less
operator-dependent. MRV can also depict, easily and glo-
bally, the anatomy and morphology of the head, intra-and
extra-cranial venous system. MRV is a comprehensive,
noninvasive and relatively operator-independent tech-
nique which provides a 3D structural assessment of the
intra and extra-cranial vasculature for the potential identi-
fication of stenosis and quantification of blood flow
through major veins [41].
Recent studies have used MRV to assess differences
between the MS population and controls with varying
degrees of success. MRV has been tested against other
imaging modalities, such as CV and DS, in detection of
venous anomalies [30,31,34,42,43,102]. Wattjes et al.
performed MRV in 20 MS patients and 20 age- and
gender-matched controls and found no significant differ-
ence in the rate of venous anomalies [40]. The authors
concluded that the anomalies in venous outflow had
likely reflected normal developmental anatomic variants.
Another study also reported no differences between 21
MS patients and 20 controls in relation to IJVs outflow
and aqueductal cerebrospinal fluid flow using phase-
contrast sequences and contrast-enhanced MRV [37].Zivadinov et al. found no difference in morphological
flow characteristics between MS patients and controls
[44]. However, Dolic et al. found that progressive MS
patients showed more morphological anomalies than
those in relapsing stages of the disease [31]. Only one
MRV study, so far, that included 19 MS patients and 20
healthy controls showed a significant difference in flow
morphology of the IJVs between the two groups [36].
MS patients had greater flattening of the IJVs than
healthy controls with no difference in collateral scores.
The findings of these studies suggest that MRV morpho-
logic information by itself may be insufficient to allow
conclusions to be drawn about the presence of venous
anomalies and their relationship to CCSVI in MS.
MRV is extremely useful in detecting collateral veins,
which probably represent physiological variations of the
venous system that may play a compensatory role when
there are more venous extra-cranial anomalies present
[30,31]. The extra-cranial venous collateral circulation
probably represents a compensatory mechanism for im-
paired venous outflow, because it bypasses blocked veins
and thereby reduces resistance to drainage [10]. The as-
sessment of the possible prominence or collateralization
of the extra-cranial veins in the neck by MRV is an im-
portant diagnostic step in examining the status of the
venous system.
Time-of-flight
During the past decade, catheter-based digital subtrac-
tion angiography, as the preferred method for imaging
of the intracranial venous anatomy, has been increas-
ingly supplanted by MRV, usually performed with a two-
dimensional time-of-flight (TOF) pulse sequence [118].
In the absence of better non-invasive techniques for the
imaging of the dural venous sinuses, well-known and
documented pitfalls associated with flow-sensitive MR
techniques have been tolerated.
Furthermore, simple protocols that incorporate 2D-
TOF acquisitions have already improved their accuracy
for the diagnosis of deep venous thrombosis involving
the femoral, popliteal or iliac veins [119]; however, ex-
perience with these techniques in the cervical veins is
still limited. Thoracic central veins are largely inaccess-
ible by DS, and MRV is an excellent technique for the
assessment of axillary, jugular, subclavian, superior vena
cava and pulmonary veins. TOF venography has the ad-
vantage of simplicity because no special pulse sequences
are required and this technique is available on nearly
every MRI system. TOF pulse sequences are spoiled
gradient-echo or gradient echo acquisitions performed
sequentially, that is, all phase encode steps are played
out in a single slice before moving on to the next slice
that results in much greater suppression of stationary
tissue. It also has the advantage of avoiding the need for
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choice in the evaluation of the pregnant patient with
suspected dural sinus thrombosis. Furthermore, the ac-
companying conventional MR study is more sensitive in
terms of the detection of cortical venous infarction than
a CT [120]. Additionally, CTV always requires the use of
intravenous contrast, while many non-contrast methods
are available with MRV, making MRV the preferred
technique in patients who also suffer from renal insuffi-
ciency or contrast allergy. CTV may also require two
or more acquisitions to adequately capture contrast
opacification of the veins, thereby increasing the radi-
ation dose [103].
The axial orientation of the acquisition allows for high
in-plane resolution, which is ideal for cross sectional
area (CSA) measurements of the veins. However, the
TOF sequence is easily affected by motion artifacts, es-
pecially from the patient’s breathing, swallowing, snoring
or head motion [38,41] (Figure 4). Relative insensitivity
to in-plane flow is another limitation of the TOF tech-
nique. Regarding the direction of flow, the optimal ac-
quisition plane lies orthogonal, which is inefficient from
the standpoint of acquisition time and not always
achievable. Although it has a higher spatial resolution
2D-TOF may overestimate stenosis in the setting of tur-
bulent or slow flow [42].
All in all, standard conventional MRV techniques are
more prone to artifacts than phase-contrast MRV and
3D-TOF angiography [10,44]. These techniques can po-
tentially alleviate some of the usual MRV artifacts and
provide more detailed flow information. One obvious
improvement is to image at higher field strength, such
as 3T, because this increases signal-to-noise ratio and
better characterizes slow flow.Figure 4 Example of normal and abnormal flow in internal jugular ve
internal jugular veins (A) and abnormal flow in left internal jugular vein onPhase contrast imaging
In contrast to TOF techniques, which rely mainly on
flow-related enhancement for producing vascular im-
ages, phase-contrast MR angiography (PC-MRI) uses
velocity-induced phase shifts imparted upon the moving
spins to distinguish flowing blood from the surrounding
stationary tissue, thus providing information regarding
both anatomy and flow (Figure 5). The major advantage
of PC-MRI angiography is excellent background sup-
pression as well as quantitative determination of blood
velocities. However, it requires long imaging times and a
prior estimate of blood flow velocity. Furthermore, it
may also be more sensitive to signal loss due to turbu-
lence or intravoxel dephasing [121,122]. So far, to the
best of our knowledge, there are only a few studies that
used PC-MRI to quantify venous flow in MS patients.
Sundström et al. studied the IJV flow normalized by the
total arterial flow at the C2/C3 levels in 21 MS patients
and 20 controls and found no statistically significant differ-
ence between the two [37]. On the other hand, Feng et al.
characterized and compared the flow characteristics in a
large cohort of the non-stenotic and stenotic MS patients
and observed significantly reduced IJV flow in the stenotic
group [41]. They concluded that a normalized total IJV flow
of less than 50% of total arterial flow may be a potential
biomarker for identifying significant stenoses in IJVs. Add-
itionally, Haacke et al. showed that patients suffering from
MS with structural venous anomalies on MRI exhibit an
abnormal flow distribution of the IJVs [35]. In contrast to
PC-MRI, Hartel et al. used very simple MRV protocol with
T2FatSat and 2D-TOF sequences for the assessment of flow
disturbances in IJVs and azygous vein [123]. They found
that abnormal flow pattern in IJVs in MS patients is more
common on the left side.in on magnetic resonance venography. Normal flow in both
axial 2D time-of-flight (B).
Figure 5 Example of internal jugular vein pathology on cine phase-contrast MRI study. The regions of interest (ROIs) outlined are the
internal jugular veins. These ROIs were used to measure the flow through these vessels. An example showing the flow quantification magnitude
image in stenotic (A) and normal IJV (B) and the flow quantification on phase images of the same IJVs (C and D). Graph showing the differences
in velocity between stenotic and non stenotic IJV (E).
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the upper neck level on an adequate number of age- and
gender-matched healthy controls with heterogeneous
age groups.
Contrast-enhanced techniques
Contrast-enhanced (CE) MRV, 3D time-resolved imaging
of contrast kinetics (TRICKS) angiography is a noninva-
sive and safe method for the evaluation of head and neck
veins, without the attendant risks of conventional angi-
ography. It is preferred over TOF angiography becauseFigure 6 Example of normal and abnormal flow morphology in intern
(A and B) flow morphology in both and abnormal (C and D) flow in the le
contrast kinetics (TRICKS).contrast medium reduces the T1 relaxation time of
blood and virtually eliminates the effect of saturation
[124,125] (Figure 6).
CE MRV is probably the most widely-used technique
and is essentially identical to 3D CE MR angiography,
employing a 3D-spoiled gradient-echo sequence in con-
junction with a bolus of gadolinium-based contrast. Vas-
cular contrast results from the T1-shortening effects of
gadolinium on adjacent water protons and has relatively
little dependence on inflow effects. In contrast to MRA,
the limitation of CE MRV is that maximal contrastal jugular vein on magnetic resonance venography. Normal
ft internal jugular vein on enhanced 3D time-resolved imaging of
Dolic et al. BMC Medicine 2013, 11:155 Page 10 of 20
http://www.biomedcentral.com/1741-7015/11/155enhancement achieved in veins is typically lower than
arteries because the contrast bolus is more dilute by the
time it reaches the venous system [126]. To improve
background suppression and emphasize vascular signal,
fat saturation can be added to a 3D spoiled gradient-
echo sequence with a small increase in acquisition time.
3D reconstruction of CE MRV data is somewhat less
straightforward than MR angiography reconstruction
since the vein/background contrast is lower and there is
usually arterial as well as venous enhancement.
Veins can have variable MR imaging signal intensity
due to entry slice phenomenon, in-plane flow, flow tur-
bulence effects and can have variable enhancement. The
maximum intensity projection (MIP) volumetric recon-
structions of these sequences often underestimate the
vascular caliber, especially when there are segments with
decreased flow (velocity or volume) [120].
Disadvantages of CE MRV include the expense of the
contrast agent, as well as contrast toxicity and patient
discomfort in obtaining antecubital venous access. In the
case of dural sinus thrombosis, however, confident early
diagnosis of this common and treatable disease can dra-
matically reduce patient morbidity.
4D flow imaging
Another promising MR technique is cine velocity-
encoded phase-contrast 4D flow that may permit evalu-
ation of not only anatomic stenoses but also their impact
on venous waveforms. It is based on the principle that
moving protons change phase in proportion to their vel-
ocity. By enabling a qualitative assessment of the pres-
ence and direction of collateral circulation, velocity-
encoded cine MR imaging provides information about
the presence and severity of obstruction. The technique
has been most extensively used for the evaluation of pat-
terns of blood flow in the thoracic aorta, including the
characterization of abnormal flow patterns associated
with pathologic disorders, such as ascending aortic
aneurysm and dissection [127]. Recent studies have ex-
plored the use of 4D flow imaging for other areas of vas-
cular anatomy and pathology, including intracranial
arterial and venous blood flow [128]. With its detailed
characterization of complex, dynamic blood-flow pat-
terns and its ability to quantify flow, the technique could
supplement both current noninvasive and invasive im-
aging of intra- and extra-cranial vascular pathologic dis-
orders. The diagnostic and monitoring value of 4D flow
imaging of venous flow anomalies, indicative of CCSVI,
is currently lacking.
Further pitfalls and considerations
Finally, MRV suffers from its "snapshot" nature. An ac-
curate depiction of these veins requires multiple views
and maneuvers, such as inspiration and expiration,flexion and extension as well as rotation imaging of the
neck. Its main disadvantages are the lack of MRV dyna-
mism in real time, lower resolution compared with DS
and CV (cannot evaluate intra-luminal pathology, such
as the immobile valves, webs, septations, membranes
and duplications) and it is affected by the nature of the
veins themselves, which are prone to collapse under
frequently encountered conditions, as opposed to ar-
teries. MRV often detects spurious stenoses that are
not confirmed by CV, especially in the lower parts of
IJVs [42,123]. These stenoses may represent transient
phasic narrowings (functional) or may result from di-
minished flow above true stenoses commonly located
at the confluent region of the veins [30,31,102,123].
Additionally, it cannot satisfactorily evaluate the azy-
gous and hemiazygous veins.
Unlike DS, with most MR scanners, data can only be
collected in the supine position, although some scanners
can do an upright scan as well. Niggemann et al. used
positional MR imaging to describe the influence of pos-
itional changes on the cerebral venous outflow [129].
They found that IJV strictures are a common finding in
healthy controls in the supine position without relevance
in the erect position, which questions the validity of the
DS VH criterion 5 (lack of collapse of the IJV in upright
posture) for the diagnosis of CCSVI. It is obvious that
this criterion (to study the change in flow in the IJVs
from supine to sitting position) cannot be studied with
the conventional MR system [130].
Computed tomography venography
The development of spiral CT has greatly extended the
range of venous evaluation. Previous reports have noted
that CTV has a high sensitivity for depicting the intrace-
rebral venous circulation as compared with digital sub-
traction angiography [103]. Advantages of CTV over CV
include decreased cost, noninvasiveness and time to
diagnosis. The CTV source images can also demonstrate
parenchymal anomalies not detectable with CV and it
has the ability to display images in rotating three-
dimensional cine loops (as well as MRV), which provides
a virtually limitless number of views from a single injec-
tion [104].
Further, CTV is superior to MRV in the identification
of cerebral and extra-cranial veins and dural sinuses
based on speed along with spatial resolution, and is at
least equivalent in establishing the diagnosis of dural
sinus thrombosis. It is also less expensive and less time
consuming. Examination is very short; hence, the image
quality is hardly impaired by patient motion, putting it
as a first choice in critically ill patients [5]. Many pa-
tients who are not candidates for MRV by virtue of
pacemakers, other MRI incompatible devices or claus-
trophobia can be examined with CTV. On the other
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higher with MRV. CTV also, like MRV, cannot evaluate
intra-luminal vein pathology, such as the immobile valves,
webs, septum, membranes and duplications. In relation to
CCSVI, some of the main advantages of CTV may be re-
lated to venous multi-planar and global venous system
evaluation, possibility of direct assessment of the azygos
vein (morphology, caliber, course and possible calcifica-
tions) and use for therapeutic planning [10]. Nevertheless,
there are no case–control CTV studies in MS patients.
This is most likely due to the potential for radiation expos-
ure to controls and need for use of a contrast agent. Our
group gained preliminary experience by using CTV as part
of a multimodal diagnostic approach in a currently on-
going “Prospective Randomized Endovascular Therapy in
MS (PREMiSe)” study (Figure 7).
Invasive imaging modalities
Catheter venography
CV is usually considered to be the “gold standard” for
defining the degree of stenosis in blood vessels associ-
ated with altered blood flow [28,42,45,48]. However, it
has been found to be less sensitive in revealing the exact
nature of narrowed extra-cranial vein segments. Al-
though CV is a luminogram, it brings little or no data
regarding the vessel's intra-luminal structures, because
of dense opacification of the lumen with contrast, whichFigure 7 Example of computerized tomography venography of intern
jugular veins. Axial and sagittal reconstructions of azygos vein (B and C) arobliterates subtle intra-luminal structures. Although it is
excellent in detecting larger intrusions, such as athero-
mas into the lumen, it has limited potential to detect
lesions, such as intra-luminal valve malformations, septa
and flaps [10,107]. Though it is possible to use very
dilute contrast and cone-downed images at high rates
of acquisition to pick up some of these intra-luminal
features, they are generally harder to detect on CV
using conventional acquisition parameters and contrast
strengths. Therefore, in cases where only the intra-
luminal venous anomalies or developmental variants are
present, it is extremely difficult to measure the degree of
flow obstruction by CV. In addition, malformed and/or
reversed valve cusps can be crossed by the catheter and
kept open artificially, thereby preventing the documenta-
tion of stenosis. Conversely, CV has several important
advantages, including the ability to perform pressure gra-
dient measurements as well as to provide a helpful “road
map” for planning endovascular procedures [28,46,107].
However, its invasiveness, use of contrast agents and radi-
ation exposure make it suboptimal as a routine screening
tool in a clinical setting. It is also operator dependent, only
AP projection views are routinely obtained and stenosis
assessment may depend on the precise locations and rates
of contrast injection.
One of the main criticisms of the CCSVI concept
arose from the use of endovascular procedures toal jugular and azygos veins. Axial (A) reconstructions of internal
e shown, but their diagnostic value is questionable.
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label fashion without previously establishing a) diagnostic
imaging modalities and protocols that will serve as a “gold
standard” for the detection and monitoring of these extra-
cranial venous anomalies and b) safety as well as efficacy of
the endovascular procedures in randomized, double-blinded,
sham-controlled studies [10,28,46,49,62-66,69,71,131]. Fur-
thermore, classification, existence and interpretation of ven-
ous anomalies are questionable, given the fact that the same
can be found among healthy populations [40,85,88,98]. At
this time, it remains unclear whether extra-cranial venous
anomalies represent an acquired pathology or developmen-
tal variants. Future longitudinal studies need to elucidate
these important questions.
The challenge at this moment, given the early stage of
CCSVI related studies, is in defining the venous anomal-
ies and developmental variants being detected with CV
and the criteria being used to make subsequent treat-
ment decisions. Additionally, there are lingering ques-
tions regarding the best vascular access. These questions
include: Whether to use diluted or non-diluted contrast?
Should these veins be evaluated irrespective of their
diameter and anatomy of the venous network? What pa-
rameters should define pathological valve and other
intra-luminal structures and should routine CV of these
veins always be accompanied by intravascular ultrasound
(IVUS) [48,108]?
It is apparent that the invasive methods for the assess-
ment of hemodynamic stenoses in the extra-cranial ven-
ous system, (mostly IJV and azygos veins), are not
optimal. The first finding to consider when evaluating a
patient for CCSVI is the degree of narrowing within
the vein as seen on CV and the decision as to what
constitutes a significant stenosis. The IJV is often not a
circular object; often being oval or complex. Thus, deter-
mination of the diameter of the vein by CV is often
arbitrary and, therefore, it under- or over-estimates the
proper size of the balloon for the angioplasty [108]. The
concept of a significant obstruction being when the ves-
sel has been reduced to 50% of its diameter, (which cor-
responds to a 75% reduction in CSA), is derived mainly
from observations in the arterial system. However, these
criteria may not be applicable in the venous system be-
cause there are some fundamental differences. One po-
tential issue is that the IJV can vary significantly in both
size and symmetry with various factors, including hydra-
tion status, cardiac output, respiratory excursions as well
as head position that can account for some of the noted
variability [26]. Using DS at the level of the cricoid car-
tilage, Lin et al. found that the normal venous diameter
ranged from 9.1 mm to 10.2 mm but that a small IJV
(5 mm in diameter) can be seen in 13.5% of subjects on
the right side and in 10.6% on the left side [132]. In light
of the high pressures necessary to dilate the stenosis,proper sizing is crucial to avoid injury to the vein
by over dilation- or early recurrent stenosis by under-
dilatation (Figure 8). More sophisticated categorical
criteria (ranging from grade 1 to grade 4) have been re-
cently proposed [46] but they need to be tested and vali-
dated. Further, there is the concern that an intra-luminal
anomaly, such as septae, may easily be displaced out of
the way by an inflated balloon but upon deflation fall
right back in its original position and continue to func-
tionally obstruct flow.
CV can only show the collaterals that drain the specific
vein being injected without the possibility of showing
the global extra-cranial venous system at once, that is, as
with MRV or CTV [10,43]. The display of extra-cranial
venous structures can be improved with additional
injected contrast medium, more selective catheterization
and additional projections.
Although a number of open-label studies evaluated
extra-cranial veins in MS patients and showed a high
prevalence of venous anomalies [28,43,45-51,107,133],
there are no data available comparing CV findings in
MS patients and age- and sex-matched controls. The
availability of such studies is essential in determining the
potential prevalent differences between venous anomal-
ies or developmental variants, indicative of CCSVI and
their general distribution in the healthy pediatric and
adult population with respect to age and gender.
Future considerations
CV can be complemented by use of more sophisticated
criteria such as time to empty contrast from the vein or
wasting of the balloon across a stenosis [134]. Further,
with the ability to perform pressure gradient measure-
ments before and after the endovascular procedures it
can indirectly give the information about hemodynamic
significance of venous obstruction [28].
Intravascular sonography
Intravascular sonography (IVUS) is an endoluminal CV-
based US technique that offers a tomographic, 360° view
of the vessel’s wall from the inside. It also allows more
complete and accurate assessment than is possible with
the use of CV examination. Therefore, IVUS imaging
may reflect truly the size of stenotic lesions. It provides
cross-sectional, in vivo visualization and the demonstra-
tion of the motility of small intra-luminal structures,
which cannot be optimally revealed by traditional diag-
nostic methods [135].
The most common indications for IVUS have been in
the evaluation and treatment of arterial disease. Its ex-
cellent resolution compared with angiography has con-
tributed to the understanding of the pathophysiology
and enhanced diagnosis of coronary artery disease
achieving new milestones in interventional cardiology
Figure 8 Catheter venography of azygos and internal jugular veins. Example of normal patent lumen of the azygos vein (A) and left
internal jugular vein (IJV) (B). Significant stenosis of the proximal right IJV (C).
Dolic et al. BMC Medicine 2013, 11:155 Page 13 of 20
http://www.biomedcentral.com/1741-7015/11/155[136-138]. IVUS has been shown to provide a more ac-
curate assessment of vessel circumference and cross-
sectional area and thus, is useful in detecting critical
stenoses. Analysis of the vessel dimensions allows a
more accurate selection of balloon size, thus reducing
the risk of injury and providing a more effective angio-
plasty [139,140]. Abnormal valves characterized by
highly echogenic irregular thickening, poor mobility,
bulging cusps, as well as septum, and webs are more
easily seen by IVUS because they are highly echogenic.
It has been shown that such venous pathology in the
iliac vein is unrecognized by CV and is well visualized by
IVUS [141].
Although diagnostic experience is growing with the
use of IVUS for investigation of both intra- and extra-
cranial arteries [142], there is limited literature regarding
its use for the exploration of venous vasculature in gen-
eral, as well as specifically in relation to the investigation
of venous anomalies and developmental variants indica-
tive of CCSVI [47,107,108] (Figure 9). It is our experi-
ence that IVUS is more accurate in the detection of
intra-luminal venous anomalies in IJVs and azygos vein,
more accurate in measurement of stenosis and wallFigure 9 Example of intravascular ultrasound in the internal jugular v
fibrotic wall.thickness and allows for the exploration of pulsatility in
the veins [134]. The exploration of IJV valves is particu-
larly well-seen on IVUS. Additionally, thrombus and dis-
sections are readily seen on IVUS [108]. IVUS can also
show the degrees of echogenicity, both of the vessel wall
and of the intra-luminal thrombi, which may indicate
varying degrees of wall thickness and may correlate with
the age of the thrombosis, an important aspect of the
vessel pathology that is not possible to be determined
with CV [143].
In a recent study that included 45 MS patients, Scalise
et al. found that CV was significantly inferior to DS and
IVUS in detecting intra-luminal anomalies. IJV CSA was
under-estimated by DS compared to IVUS [107]. In an-
other study, Lugli et al. retrospectively examined 167
consecutive MS patients who presented ≥2 positive DS
VH criteria [47]. In 37% of the cases there was no cor-
relation between the preoperative DS assessment and
the CV findings. In the event of incongruity between the
two exams, IVUS was performed and confirmed DS
findings in 42% of cases and CV results in 58%. Karmon
et al. have explored the prevalence of extra-cranial ven-
ous anomalies in IJVs and azygous using CV as well asein. Normal patent lumen (A) and stenotic lumen (B) with
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criteria [132]. CV was considered abnormal when ≥50%
lumen restriction was detected, whereas IVUS was con-
sidered abnormal when ≥50% restriction of the lumen or
intra-luminal defects or reduced pulsatility was found.
Venous anomalies detected by IVUS were observed in
85% of azygous vein, 50% of right IJVs and 83.3% of left
IJVs, whereas CV showed stenosis of ≥50% in 50% of
azygous vein, 55% of right IJVs and 72% of left IJVs. CV
sensitivity for detecting IVUS anomalies was 52.9%,
73.3% and 80% for the azygous vein, left IJV and right
IJV, respectively. This study showed that the IVUS as-
sessment of IJVs and azygous vein can detect higher
rates of venous anomalies than CV and that provides a
diagnostic advantage over the "gold-standard" CV in
detecting extra-cranial venous anomalies and develop-
mental variants indicative of CCSVI.
Advantages
The advantages of IVUS compared with DS, among
others, include the sonographic penetration from within
the vessel by excluding extra-vascular soft tissues. It also
assesses blood vessels not easily accessible by conven-
tional DS, such as the lower part of the IJV (behind the
clavicle), upper part of the IJV, intracranial sinuses and
azygos vein. Additionally, it provides an image with a
greater resolution of both lumen and wall (with add-
itional 3D features), providing better vessel wall informa-
tion. IVUS is superior in identifying intra-luminal
venous anomalies/development variants compared to
CV [107,108,134]. Moreover, CV is incapable of moni-
toring respiratory pulsatility which involves periods with
reduced vessel diameter that can be investigated with
IVUS. While values for stenosis definition used for CV
(≥50%) rely on a ratio between the stenotic segment
diameter and a pre-(non) stenotic vein, which is more
variable, the IVUS definition is more strict (a lumen that
embraces the IVUS probe for a critical stenosis) and
does not refer to a non-stenotic segment [134]. It re-
mains unclear at what level and with what criteria is
there a significant hemodynamic effect of stenosis by ei-
ther modality. Venous stenosis is currently measured
using arterial criteria, which are clearly not optimal. The
hemodynamics of venous flow remain a major area of
investigation and better understanding will likely lead to
a revision of stenosis criteria.
Disadvantages
Ring-down artifacts produced by acoustic oscillations in
the piezoelectric transducer that obscures the near field,
results in an acoustic catheter size larger than its phys-
ical size and may adversely affect IVUS images [144].
Geometric distortion can result from imaging in an ob-
lique plane (not perpendicular to the long axis of thevessel) [145]. Furthermore, visible distortion of the
image can be due to another important artifact, "non-
uniform rotational distortion" , which arises from uneven
drag on the drive cable of the mechanical style catheters,
resulting in cyclical oscillations in rotational speed. The
physical size of IVUS catheters (currently approximately
1.0 mm) constitutes an important limitation in the im-
aging of severe stenoses [146]. Further, depending on the
probe there is a finite limit to IVUS resolution which
rapidly degrades beyond this particular radius typically
10 to 12 mm. In summary, the frequency of the trans-
ducer, gain settings, depth of penetration and focal depth
are some of the factors that affect the sensitivity of the
IVUS imaging.
Further considerations
Further studies are needed to validate the role of IVUS in
depicting extra-cranial venous anomalies and developmen-
tal variants, indicative of CCSVI. Protocol optimization and
standardization are needed to make this imaging method
more widely used. Preliminary IVUS studies that investi-
gated extra-cranial venous anomalies and developmental
variants have been extremely important in better under-
standing these structures [47,107,108,134].
Plethysmography
Plethysmography is the only existing practical noninva-
sive modality for global physiologic evaluation of ex-
tremity veins. As such, it provides valuable information
regarding the impact of reflux and obstruction on overall
venous function and can provide a measure of calf
muscle pump function (strain-gauge plethysmography)
[147,148]. The identification and assessment of venous
obstruction by plethysmography is based on an estima-
tion of these two parameters: venous capacitance and
venous resistance.
The use of plethysmography as a complementary mo-
dality to DS is reasonable for quantification of reflux or
obstruction, for monitoring the dynamics of venous dis-
ease over time and for the evaluation of treatment out-
comes. Despite their value in the anatomical localization
of disease, imaging modalities such as DS and CV cannot
assess the global severity of reflux or obstruction. More-
over, the use of strain-gauge or air-plethysmography to
diagnose venous thrombosis in the lower extremities has
been well- documented [148,149]. By inflating a cuff on
the thigh, the constriction of veins causes the venous vol-
ume to rise. When the cuff is released, the sensor detects
rapid venous runoff and a return to the resting blood
volume. If thrombosis is present, the plethysmography
will detect a delay in the emptying process. Unfortunately,
as with their invasive counterparts, most of the non-
invasive tests display the fundamental dichotomy of pro-
viding either anatomic or hemodynamic information.
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rate due to venous compression arising from incorrect pa-
tient positioning or the action of extrinsic masses. It is also
a time-consuming method [149].
Quite recently, plethysmography has been used to
measure endothelial function as well as the vascular re-
sponse to vasoactive agents [150]. The technique is
rarely used in the cervical region. Zamboni et al. re-
cently showed that cervical plethysmography is much
less prone to operator error compared to DS and has
great potential to be used as an inexpensive diagnostic
tool for demonstrating extra-cranial venous anomalies
and development variants [105]. Further, Begss et al.
conducted a study with 40 controls and 44 CCSVI pa-
tients who underwent cervical plethysmography, which
involved placing a strain-gauge collar around their necks
and tipping them from the upright (90°) to supine position
(0°) in a chair and demonstrated that hemodynamics of
the extra-cranial venous system are greatly altered in
CCSVI patients [106].Figure 10 Example of multimodality imaging of extra-cranial neck ve
Therapy in MS). Axial 2D time-of-flight (A), enhanced 3D-time resolved im
venography (E), intravascular sonography (F) and axial computed tomogra
jugular vein (narrowing).Further considerations
Apart from these early studies, little work has been done
on the application of cervical plethysmography in the de-
tection of extra-cranial venous anomalies and develop-
mental variants. Further research is needed in identifying
cutoff values, the reproducibility of the test along with
assessing intra- and inter-observer variability. This meth-
odology also shows great potential in monitoring postop-
erative patients after restorative endovascular procedures.
Multimodal imaging approach
The dramatic difference in prevalent findings between
different studies using non-invasive and invasive im-
aging techniques (ranging from 0% to 100%) empha-
sizes the urgent need for the use of a multimodal
imaging approach for better understanding of the ven-
ous anomalies and developmental variants being con-
sidered in CCSVI [10]. In a number of recent studies,
noninvasive and invasive imaging techniques were applied
and compared [18,27,30,31,34,42,43,47,50,81,82,102,107,134].ins in the PREMiSe study (Prospective Randomized Endovascular
aging of contrast kinetics (B and C), Doppler sonography (D), catheter
phy venography (G) all showing venous abnormality of the left internal
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to understand the true prevalence of CCSVI and the
comparison of invasive vs. noninvasive imaging find-
ings is especially important in this endeavor. It is
emerging that the prevalence of venous anomalies and
developmental variants, indicative of CCSVI is even
higher, when investigated with sophisticated invasive
imaging techniques [47,107,108,134]. Based on these re-
cent findings, a multi-modal approach is recommended to
determine whether CCSVI exists as a clinical entity and
not as an anatomic variant, and to what extent it is present
in various healthy and disease groups as well as MS sub-
types (Figure 10). The introduction of more quantitative
criteria to describe extra-cranial venous structural and
hemodynamic functional impairment in future multi-
modal approach studies will be a significant improvement
compared to the current binary CCSVI diagnosis.
Conclusions
The use of noninvasive methods, such as DS, to confirm
the diagnosis of CCSVI presently remains controversial.
A consensus on DS protocols to ensure appropriate
quality control for the determination of venous anomal-
ies and developmental variants, indicative of CCSVI is
essential [32,33,113]. Although a number of authors have
proposed use of MRV as an alternative noninvasive diag-
nostic approach, no consensus currently exists. Thus, at
present, the true prevalence of CCSVI in MS patients
versus controls has not been adequately assessed.
Diagnostic studies in diseased and control populations
using invasive imaging techniques, such as CV and
IVUS, to detect venous anomalies and developmental
variants indicative of CCSVI are essential to determine
their true prevalence.
Because of the complexity and variability of the extra-
cranial venous system, it is almost impossible to take all
of the factors mentioned above into account, regardless
of the imaging modality used. Each noninvasive and in-
vasive imaging modality has its own inherent advantages
and disadvantages (Tables 1 and 2). Most likely, only
multimodal imaging will eventually become the reliable
screening, diagnostic and monitoring tool for the assess-
ment of the extra-cranial venous system.
Further research is needed to determine the spectrum
of extra-cranial venous anomalies and developmental
variants and to compare findings against pathological ex-
aminations [55,56]. Undoubtedly, the attention being fo-
cused on CCSVI has significantly contributed to the vast
surge in research on the extra-cranial venous system.
Unfortunately, as a consequence of uncritical use
of endovascular procedures, an increasing number of
adverse events have been reported after angioplastic pro-
cedures for CCSVI. The ability to diagnose CCSVI non-
invasively will be an essential step toward betterunderstanding of its importance in general population
and disease states.
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